As the coronavirus vaccine being developed by Oxford university and AstraZeneca enters the third phase of the trials, Serum Institute of India (SII) is geared up to procure a licence from the Indian regulator to start clinical trials in the country in a week’s time. Serum Institute of India, the largest vaccine manufacturer in the world, and a partner in ...

Read More »